The Human Brain Research Center at Taichung Veterans General Hospital, Taiwan

IDENTITY:

Name and Family Name: Mesut Cetin

Date of Birth and Place: Usak, Turkey, 1957

Marital Status: Married 

Work Address: Caddebostan Mahallesi,Bagdat Caddesi 226 Birgen Plaza 7  Kadikoy,  34728 Istanbul/Turkey

2.EducatIon :

Undergraduate: M.D.

School of Medicine of Ege University Bornova-Izmir/Turkey 1976-1980

Graduate: Specialist (Psychiatrist) Department of Psychiatry, Gülhane Military Medical  Academy (GMMA)

Professional Experiences:

2015-  Private Practice

1999-   Professor of  Psychiatry, Head, Dept. of Psychiatry, GMMA Haydarpasa Training Hospital

1996- 2011  Director of  Dept. of  Psychiatry,  GMMA  Haydarpasa   Hospital, ISTANBUL

1991-1999  Associate  Professor of Psychiatry,

1989-1991 Assistant Prof. of Psychiatry, Department GMMA Haydarpasa Training Hospital Kadikoy-Istanbul

3. OTHER INFORMATION:

3.1 Skills and Expertise
• Psychopharmacology
• Clinical Psychiatry
• Biological Psychiatry
• Neuropsychopharmacology
• Psychoeducation
• Clinical Neuroscience
• Psychoneuroendocrinology
• CNS Pharmacology
3.2 Languages
• Turkish
• English
3.3 Contact information

Editor in Chief, Psychiatry & Clinical Psychopharmacology – Psychiatry & Behavioral Sciences
Honorary President of Turkish Association for Psychopharmacology/General Secretary of Turkish Association for Psychopharmacology

Personal Website: https://www.profmesutcetin.com/
Mobile GSMs: +90-532-272-3252 AND +90-553-002- 2900
Address: Bagdat Caddesi Birgen Plaza 226/7 Ciftehavuzlar, Kadikoy 34728 Istanbul-TURKEY
e-mail addresses: psikofarmakoloji@gmail.com & prof.dr.mesut.cetin@gmail.com

4-ACADEMICAL STUDIES:

4.1 THESIS: The Role of Organicity in the Etiologies of Attention-Deficit- Hyperactivity Disorder, Primer Enuresis,and Stuttering

4.2 PUBLICATIONS and OTHER SCIENTIFIC ACTIVITIES:

4.2.1 Periodicals:
Two Medical Journals as Editor-In-Chief:

1.2. Psychiatry and Clinical Psychopharmacology (PCP)
https://psychiatry-psychopharmacology.com/

4.1.2. Psychiatry and Behavioral Sciences
https://pbsciences.org/

4.1.2. Original Papers:

1. Cetin M, Gultepe M, Ozcan A, Tarhan N, Ceylan ME, Avsar K, Cilden S, Ucuncu A, Kaya H. The role of phospholipase-A2(PLA-2) enzyme in the etiology of depression. European Neuropsychopharmacology 1992;(2):291.

2. Cetin M, Tarhan N, Ceylan ME, Burkovik Y. A double-blind comparison of the effects and side-effects of fluoxetine and placebo in the treatment of depression. Bulletin of Gulhane Military Medical Academy 1994;(36):170-173.

3. Cetin M. Efficacy and safety of sertraline in major depression. European Neuropsychopharmacology 1996;(6):18-19.

4. Cetin M. P-25 Efficacy and safety of sertraline in major depression. Topics in Catalysis 1996;(6):S18–S19. DOI: 10.1016/0924-977X(96)83837-5

5. Cetin M, Ebrinc S, Agargun MY, Yigit S. Risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Clin Psychiatry 1999;60:554.

6. Basoglu C, Cetin M, Semiz UB, Agargun MY, Ebrinc S. Premenstrual exacerbation and suicidal behavior in patients with panic disorder. Compr Psychiatry 2000;41:103-105. DOI: 10.1016/S0010-440X(00)90141-X

7. Semiz UB, Ebrinc S, Cetin M, Narin Y, Ozguven MA. Regional brain blood flow changes in the 99mTc HMPAO SPECT assessment of patients with dissociative identity disorder. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2000;10(4):176-181.

8. Sayar K, Kose O, Ebrinc S, Cetin M. Hopelessness, depression and alexithymia in young Turkish soldiers suffering from alopecia areata. Dermatology and Psychosomatics 2001;(2):12–15. DOI: 10.1159/000049631

9. Ebrinc S, Top C, Oncul O, Basoglu C, Cavuslu S, Cetin M. Serum interleukin-1 alpha and interleukin-2 levels in patients with schizophrenia. J Int Med Res 2002; 30: 314-317.

10. Basoglu C, Cetin M, Semiz UB. Hypnotizability, pain treshold and dissociative experiences in patients with borderline personality disorder and self-mutilating behavior. European Neuropsychopharmacology 2002;12:(Suppl.3)S433-S434. DOI: 10.1016/S0924-977X(02)80758-1

11. Cetin M, Basoglu C, Ebrinc S, Balibey H, Baykiz AF, Maden B. The efficacy and safety of olanzapine in combination with valproate or lithium in the treatment of mania . European Neuropsychopharmacology 2002;12:(Suppl.3):S323.

12. Cetin M, Turgay A. Antipsychotic Treatment In The Fiftieth Year Of Modern Psychopharmacology: An Update. Clinical Psychopharmacology Bulteni – Bulletin of Clinical Psychopharmacology 2002;12(4):211-226

13. Cetin M, Kose Samet, Ebrinc S, Kistak A. The assessment of the efficacy of the psychotropic drugs. Clinical Psychopharmacology Bulteni – Bulletin of Clinical Psychopharmacology 2002;12:159-164

14. Ebrinc S, Basoglu C, Cetin M, Filiz M, Sendogan N. The efficacy and safety of haloperidol and risperidone in patients with schizophrenia. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2002;12(1):6-13

15. Uzun O, Basoglu C, Cansever A, Ozsahin A, Cetin M, Ebrinc S. Body dysmorphic disorder in patients with acne. Compr Psychiatry. 2003 Sep-Oct;44(5):415-9.

16. Gultepe M, Ozcan O, Avsar K, Cetin M, Ozdemir AS, Gok M. Urine methylmalonic acid measurements for assessment of cobalamin deficiency related to neuropsychiatric disorders. Clin Biochem 2003;36:275-282.

17. Cetin M, Ebrinc S, Basoglu C, Semiz UB, Cobanoglu N, Can S, Karaduman F. Factors affecting the satisfaction of recruits with the military environment.Turk Psikiyatri Derg. 2003 Summer;14(2):125-33.

18. Cetin M, Ebrinc S, Kandilcioglu H, et al. An investigation of some brain regions with proton magnetic resonance spectroscopy (1H-MRS) method in patients with first episode and chronic schizophrenia. European Neuropsychopharmacology 2004;14:(Suppl.3)S239-S239.

19. Cetin M, Ebrinc S, Kandilcioglu H, Basoglu C, Basar US, Silit E, Kizilkaya E, Gunay H, Gunay H, Iyisoy M S. An investigation of some brain regions with proton magnetic resonance spectroscopy (1H-MRS) method in patients with first-episode and chronic schizophrenics. European Neuropsychopharmacology 2004;14:(Suppl.3)S239.

20. Ebrinc S, Cetin M, Oner O. Atypical antipsychotics in treatment of bipolar disorder in special populations. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2004;(14):236-250.

21. Ebrinc S, Semiz UB, Basoglu C, Cetin M, Baykiz AF, Kandilcioglu H, Balibey H. Efficacy and safety of amisulpride treatment in schizophrenia: Comparison with haloperidol Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2004;14(3):143-149.

22. Semiz UB, Turhan V, Basoglu C, Oner O, Ebrinc S, Cetin M. Leptospirosis presenting with mania and psychosis: four consecutive cases seen in a military hospital in Turkey. Int J Psychiatr Med 2005;35:299-305. DOI: 10.2190/0KUX-JE1J-HV6K-3R9J

23. Semiz UB, Basoglu C, Cetin M, Ebrinc S. Panic disorder due to ingestion of single dose ecstasy. Int J Psychiatr Clin Pract 2005; 9: 138-141. DOI: 10.1080/13651500510028968

24. Semiz U, Basoglu C, Cetin M, Ebrinc S, Uzun O, Ergun B. Body dysmorphic disorder in patients with borderline personality disorder: A preliminary study. European Neuropsychopharmacology 2005; 15:(Suppl.3)S651-S651. DOI: 10.1016/S0924-977X(05)81382-3

25. Cetin M, Kose M. Identification and posttraumatic stress disorder symptoms in rescue workers in Marmara, Turkey, earthquake. J Traumatic Stress 2005;18:485-489.

26. Cetin M, Ebrinc S, Basoglu C, Semiz UB. Efficacy and safety of long-acting injectable risperidone in schizophrenia: a 12 week open-label study in stable patients switched from typical and atypical oral antipsychotics. European Neuropsychopharmacology 2005;15:(Suppl.2)S134-S135.

27. Semi UB, Basoglu C, Ebrinc S, Ergun BM, Noyan CO, Cetin M. Body dysmorphic disorder, trauma, and dissociation in patients with borderline personality disorder: a preliminary study. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2005;15:65-70.

28. Basoglu C, Cetin M, Oner O. Comparison of rigid thalamus and temporal cortex metabolite levels of drug-naive first episode psychotic and chronic schizophrenia inpatiens. Turkish Journal of Psychiatry 2006;17:8591.

29. Herken H, Erdal ME, Cetin M, Barlas O, Basoglu C, Uzun O, Selek S, Gokdogan T. Association between 5-HT2A receptor gene T102C and 1438G/apolymorphism and clozapine treatment response American Journal Of Medical Genetics Part B- Neuropsychiatric Genetics 2006; 141B(4):786-787.

30. Cetin M, Basoglu C, Ebrinc S. U, Semiz B, Algul A, Oguz M. Long acting risperidone in treatment of non-compliant bipolar patients. European Neuropsychopharmacology 2006;16(4):S365-S366.

31. Cetin M, Karagozoglu M. Olanzapine-induced metabolic side effects, switching from olanzapine to ziprasidone: A pilot study. European Psychiatry 2007;22:(Suppl.1)S108-S108.

32. Algul A, Semiz U. B, Ates M. A, Cetin M, Ebrinc S, Basoglu C, Gunay H, Gunes C, Noyan C. O, Yilmaz O. Subjective sleep quality and aggression in antisocial personality disorder. European Psychiatry 2007;22:(Suppl.1)S288

33. Algul A, Semiz UB, Cetin M, Dundar O, Ates MA, Basoglu C, Ebrinc S, Gunay H, Iyisoy S. Risk factors for postpartum depression: A preliminary study . European Psychiatry 2007;22:(Suppl.1) S221-S222.

34. Cetin M, Semiz UB, Iyisoy MS, Basoglu C, Ates A, Ebrinc S. Comorbidity of adult attention deficit hyperactivity disorder and its relation to executive functions in patients with antisocial personality disorder European Psychiatry 2007;22:(Suppl.1) Q270.

35. Semiz UB, Cetin M, Senol MG, Noyan O, Ates A, Basoglu C, Ebrinc S. Relationship of subjective sleep quality, daytime sleepiness, and depression to the quality of life in patients with Parkinson’s disease. European Psychiatry 2007;22:(Suppl.1)S339.

36. Semiz UB, Senol MG, Basoglu C, Noyan O, Ebrinc S, Cetin M, Saracoglu M. Relationship of depressive symptoms and subjective sleep disturbances to the quality of life in patients with Parkinson’s disease. Neurol Psychiatr Brain Res 2007;14:55-58.

37. Semiz UB, Basoglu C, Ebrinc S, Cetin M. Childhood trauma history and dissociative experiences among Turkish men diagnosed with antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol. 2007 Nov;42(11):865-73. Epub 2007 Aug 24. DOI: 10.1007/s00127-007-0248-2

38. Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1330-6. Epub 2007 Jun 12. DOI: 10.1016/j.pnpbp.2007.06.002

39. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, Basoglu C, Cetin M. A case with euprolactinemic galactorrhea induced by escitalopram . Int J Psychiatry Med. 2007;37(3):275-8. DOI: 10.2190/PM.37.3.d

40. Semiz UB, Ates MA, Algul A, Iyisoy MS, Gunes C, Basoglu C, Cetin M.The prevalence of substance use disorder in male subjects with antisocial personality disorder. Bulletin of Clinical Psychopharmacology 2007;(17):162–166.

41. Dilbaz N, Karamustafaliolu O, Oral T, Onder E, Cetin M. Evaluation of compliance to treatment and factors affecting compliance for schizophrenia outpatients Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2006;16(4):223-232.

42. Ates M, Alpay AA, Gecici O, Semiz UB, Turhan V, Cetin M. Acute psychosis due to neurobrucellosis: a case report. Anatolian Journal of Psychiatry 2008;9:188-190.

43. Ebrinc S, Semiz UB, Basoglu C, Cetin M, Agargun MY, Algul A, Ates A. Self-mutilating behavior in patients with dissociative disorders: the role of innate hypnotic capacity. Isr J Psychiatry Relat Sci. 2008;45(1):39-48.

44. Algul A, Semiz UB, Dundar O, Ates MA, Basoglu C, Ebrinc S, Doruk A, Gecici O, Cetin M. Psychosocial and hormone related risk factors for early postnatal depressive symptoms in turkish women. Neurology, Psychiatry and Brain Research 2008:15:117-122().

45. Semiz UB, Basoglu C, Ebrinc S, Cetin M. Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder. Psychiatry Clin Neurosci. 2008 Feb;62(1):48-55. DOI: 10.1111/j.1440-1819.2007.01789.x

46. Semiz U, Basoglu C, Cetin M, Ebrinc S, Uzun O, Ergun B. Body dysmorphic disorder in patients with borderline personality disorder: prevalence, clinical characteristics, and role of childhood trauma. Acta Neuropsychiatrica 2008:20:33-40. DOI: 10.1111/j.1601-5215.2007.00231.x

47. Basoglu C, Semiz U, Oner O. Gunay H, Ebrinc S, Cetin M, Sildiroglu O, Algul A, Ates A, Sonmez G. A magnetic resonance spectroscopy study of antisocial behavior disorder, psychopathy and violent crime among military conscripts. Acta Neuropsychiatrica 2008:20:72-77

48. Semiz UB, Basoglu C, Oner O, Munir KM, Ates A, Algul A, Ebrinc S, Cetin M. Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust NZJ Psychiatry. 2008 May;42(5):405-13. DOI: 10.1080/00048670801961099

49. Semiz UB, Algul A, Basoglu C, Ates MA, Ebrinc S, Cetin M, Gunes C, Gunay H. The relationship between subjective sleep quality and aggression in male subjects with antisocial personality disorder. Turkish Journal of Psychiatry. Winter 2008;19(4):373-81.

50. Ebrinc S, Algul A, Ates MA, Semiz UB, Gecici O, Basoglu C, Cetin M. Efficacy and safety of long-acting injectable risperidone during treatment of manic episode with non-compliance bipolar patients. Neurol Psychiatr Brain Res 2008:15:38-44.

51. Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet 2008 Apr 30.

52. Ates MA, Algul A, Gecici O, Semiz UB, Noyan O, Basoglu C, Ebrinc S, Uzun O, Cetin M. Substance use in early adult male with first episode psychosis . Neurol Psychiatr Brain Res 2008:15:93-98.

53. Algul A, Ates MA, Gulsun M, Semiz UB, Gecici O, Noyan O, Cetin M. Epileptic seizure precipitated by using venlafaxine-extended release form: a case report. Noropsikiyatri Arsivi – Archives of Neuropsychiatry 2008;45(2):62-64(in Turkish).

54. Cetin M, Antidepressants, antipsychotics: Reliability of metaanalyses. Bulletin of Clinical Psychopharmacology, 2008:18(4):245-250(in Turkish).

55. Semiz UB, Algul, A, Cetin M. Alexithimia and aggression in patients with antisocial personality disorder. European Psychiatry 2008;23:(Suppl.2) S91.

56. Algul A, Semiz UB,Ates MA, Cetin M. Association between psychosocial distress, subjective sleep qualityof life in patients with obesity: A preliminary study.European Psychiatry 2008;23: (Suppl.2)S62-S63.

57. Ebrinc S, Sahan A, Semiz UB, Cetin M. Effect of sertraline treatment on regional cerebral blood flow in OCD. European Neuropsychopharmacology 2008;18:(Suppl. 4)S62-S63.

58. Ebrinc S, Semiz UB, Oznur T, Cetin M. Neuropsychological assessment of unmadecated patients with OCD. European Neuropsychopharmacology 2008;18:(Suppl. 4)S62-S63.

59. Algul A, Ates MA, Semiz UB, Basoglu C, Ebrinc S, Gecici O, Lyisoy S, Cetin M. Relationship of substance use disorder to aggression in male subjects with antisocial personality disorder European Psychiatry 2008; 23(Suppl.2):S91

60. Algul A, Ates MA, Gulsun M, Doruk A, Semiz UB, Basoglu C, Ebrinc S, Cetin M. The relationship between self-mutilation, aggression, childhood trauma history and dissociative experiences in antisocial personality disorder Anadolu Psikiyatri Dergisi- Anatolinan Journal of Psychiarty 2009;10:278-285(in Turkish).

61. Ates MA, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M. Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder. International Journal of Social Psychiatry 2009. DOI: 10.1177/0020764008099339

62. Algul A, Ayata A, Ates MA, Doruk A, Perdeci Z, Basoglu C, Semiz Ü B, Gulsun M, Ebrinc S, Cetin M, Ersanli D. The temperament and character structure of the central serous chorioretinopathy patients and correlation with anxiety and depression level. A preliminary report. Bulletin of Clinical Psychopharmacology 2009:19(Suppl. 1):S241-S244.

63. Algul A, Ozflahin A, Ates MA, Basoglu C, Semiz UB, Ebrinc S, Doruk A, Perdeci Z, Cetin M.The relationship between the menopausal depression and previous depressive episode, and family history of depression, and life events Bulletin of Clinical Psychopharmacology 2009:19(Suppl. 1):S247-S249.

64. Noyan CO, Semiz UB, Basoglu C, Ebrinc S, Algul A, Ates MA, Yilmaz O, Cetin M. The relationship between decision-making process and features of psychopathy and temperament and character among subjects with antisocial personality disorder Clinical Psychopharmacology Bulletin -Bulletin of Clinical Psychopharmacology 2009:19(Suppl. 1):S257-S259.

65. Berk G, Ergun BM, Narin Y, Basoglu C, Gonul AS, Ebrinc S, Cetin M, Sungur MZ. The effects of cognitive-behavioural therapy on brain regional cerebral blood flow in obsessive compulsive disorder. European Psychiatry 2009;19(Supplement 1):S312.

66. Algul A, Sen H, M Ates, Yen T, Durmaz O, Ozkan S, Basoglu C, Semiz UB, Ebrinc S, Daglı G, Cetin M. “The effect of propofol and propofol remifentanil combination on seizure duration and hemodynamics in electroconvulsive therapy” , Clinical Psychopharmacology Bulletin, Bulletin of Clinical Psychopharmacology 2009;19:24-28(in Turkish).

67. Basoglu C, M. Ates A, Algul A, Ipcioglu M, Gecici O, Yilmaz O, Semiz UB, S Ebrinc S Gulsun M, Ozcan O, Kilic S, Cetin M. Adjuvant folate with escitalopram treatment and homocysteine, folate, vitamin B-12 levels in patients with major depressive disorderBulletin of Clinical Psychopharmacology 2009;19(2):135-142.

68. Algul A, Ates MA, Semiz UB, Basoglu C, Ebrinc S, Gecici O, Gülsün M, Kardesoglu E, Cetin M. Evaluation of general psychopathology, subjective sleep quality, and health-related quality of life in patients with obesity. Int J Psychiatry Med. 2009;39(3):297-312. DOI: 10.2190/PM.39.3.f

69. Algul, A, Gulsun M, Geç O, Ozdemir B, Basoglu C, Semiz UB, Ebrinc S, Cetin M. The relationship between alexithymia, aggression and psychopathy in young adult males with antisocial personality disorder Noropsikiyatri Arsivi – Archives of Neuropsychiatry 2009;46:135-9 (in Turkish).

70. Cetin M, Aricioglu F, Pharmacovigilance and its significance in psychopharmacology, Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology, 2009;19(4):335-339(in Turkish).

71. Cetin M, Aricioglu F. On the debate of original drug versus generic drug. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology, 2009;19(3):211-213(in Turkish).

72. Cetin M, Acikel C. In perspective of meta-analyses: Are all of the antidepressants similar? Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology, 2009;19(2):87-92(in Turkish).

73. Cetin M, Kilic S. How to comprehend the recent meta-analyses conducted on typical and atypical antipsychotics?Bulletin of Clinical Psychopharmacology, 2009;19(1):1-4(in Turkish).

74. Basoglu C, Cetin M, Oner O, Ebrinc S, Semiz UB, Kandilcioglu H, Silit E, Kizilkaya E. Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients. Turk Psychiatry Derg.2006 Summer;17(2):85-91.

75. Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):56-60. DOI: 10.1002/ajmg.b.30770

76. Atefl MA, Algul A, Semiz UB, Gunefl C, Cetin M. Amisulpiride Usage In Treatment-Resistant Tourette’s Syndrome: A Case Report. New/Yeni Symposium Journal 2009;47(1):16-18

77. Algul A, Sen H, Ates MA, Yen T, Durmaz O, Ozkan S, Basoglu C, U. Semiz B, Ebrinc S, Dagli G, Cetin M. Propofol versus propofolremifentanil combination anaesthesia in electroconvulsive therapy: Effects on seizure duration and hemodynamics. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2009;19(1):29-38.

78. Algul A, Gulsun M, Ates A, Ayata A, Basoglu C, Ebrinc S, Semiz UB, Ersanli D, Cetin M. Temperament and character in patients with central serous chorioretinopathy. Anatolian Journal of Clinical Investigation, 2009;(3):40-43.

79. Cetin M. Escitalopram in treatment of fibromyalgia: A pilot study International Journal Of Neuropsychopharmacology 2010;13:72.

80. Cetin M, Aricioglu F. Pharmacoeconomics and its importance in psychiatry. Bulletin of Clinical Psychopharmacology, 2010;20(1):1-4(in Turkish).

81. MacKay M, Cetin M, Baker G, Dursun S. Modulation of central nitric oxide as a therapeutic strategy for schizophrenia. Bulletin of Clinical Psychopharmacology, 2010;20(2):115-119.

82. Basoglu C, Oner O, Ates AM, Algul A, Semiz UB, Ebrinc S, Cetin M, Ozcan O, Ipcioglu OM. Association between symptom improvement and change of body mass index, lipid profile, and leptin, ghrelin, and cholecystokinin levels during 6-week olanzapine treatment in patients with first-episode psychosis. J Clin Psychopharmacol. 2010 Oct;30(5):636-8. DOI: 10.1097/JCP.0b013e3181f0580e

83. Cetin M. Escitalopram treatment of fibromyalgia: a pilot study. European Psychiatry 2010;25:(Suppl 1)S72.

84. Cetin M. A comparative study of atypical antiosychotics on sexual dysfunction. International Journal of Neuropsychopharmacology, 2010;(13):(Suppl. 1)S89.

85. Cetin M. The place of atypical antipsychotics in the treatment-resistant depressions Bulletin of Clinical Psychopharmacology 2010;20(Suppl. 1):S15-S25.

86. Dursun S, Hallak J, Devarajan S, Baker G, Cetin M. High-dose antipsychotic medication; A practical pocket checklist.Clinical Psychopharmacology Bulletin, Bulletin of Clinical Psychopharmacology 2010;20:187-188.

87. Aricioglu F, Cetin M. Personalized drug therapy in psychiatry: Maybe a little old or a little new, but the treatment of the future. Clinical Psychopharmacology Bulletin, Bulletin of Clinical Psychopharmacology 2010;20:269-271(in Turkish).

88. Basoglu C, Oner O, Gunes C, Semiz UB, Ates AM, Algul A, Ebrinc S, Cetin M, Ozcan O, Ipcioglu O. Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis. Int Clin Psychopharmacol. 2010 May;25(3):165-71. DOI: 10.1097/YIC.0b013e3283377850

89. Pan E, Algul A, Basoglu C, Ebrinc S, Ates MA, Semiz UB, Senol MG, Cetin M. Depression and agoraphobia in a patient with myasthenia gravis European Psychiatry 2010; 25:507.

90. Pan, E, Algul, A, Ebrinc, S, Basoglu, C, Semiz, UB, Ates, MA, Senol, MG, Cetin, M Psychiatric Mis-Diagnosis And Escitolopram Treatment of Mood And Anxiety Disorders in Myasthenia Gravis: A Case Report European Psychiatry 2010; 25:507.

91. Ates MA, Cetin M, Ebrinc S, Basoglu C, Algul A. A 39 Year Old Man With A Generalized Rash With Bupropion Xl Administration European Psychiatry 2011;26:1225.

92. Alpay Ates M, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M.Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder: relationship to psychopathy. Int J Soc Psychiatry. 2011 May;57(3):237-47. Epub 2009 Nov 11. DOI: 10.1177/0020764008099339

93. Basoglu C, Oner O, Ates A, Algul A, Bez Y, Ebrinc S, Cetin M. Temperament traits and psychopathy in a group of patients with antisocial personality disorder. Compr Psychiatry. 2011 Mar 10. [Epub ahead of print] DOI: 10.1016/j.comppsych.2011.01.003

94. Karolewicz B, Cetin M, Aricioglu F. Beyond the glutamate N-methyl D-aspartate receptor in major depressive disorder: the mTOR signaling route Bulletin of Clinical Psychopharmacology 2011;21:1-6. DOI: 10.5350/KPB-BCP201121101

95. Balibey H, Basoglu C, Lundgren S, Babaoglu MO, Yasar U, Herken H, Rane A, Bozkurt A, Cetin M. CYP1A2*1F polymorphism decreases clinical response to clozapine in patients with schizophrenia. Bulletin of Clinical Psychopharmacology 2011;21(2):93-9. DOI: 10.5455/bcp.20110622071701

96. Basoglu C, Oner O, Ates A, Algul A, Bez Y, Cetin M, Herken H, Erdal ME, Munir KM. Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality disorder: association with temperament and psychopathy. Can J Psychiatry. 2011 Jun;56(6):341-7. DOI: 10.1177/070674371105600605

97. Cetin M.Psychotropic Drug Use in Pregnancy: An Update. Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2011;21(2):161-73. DOI: 10.5455/bcp.20110706032759

98. Cetin M, Gumru S, Feyza Aricioglu F. Nanotechnology applications in neuroscience: advances, opportunities and challenges. Bulletin of Clinical Psychopharmacology 2012;22(2):115-20. DOI: 10.5455/bcp.20120621044747

99. Cetin M, Aricioglu A, Acikel CH, Kilic S. Today’s psychopharmacological treatments: results, problems, new perspectives. Bulletin of Clinical Psychopharmacology 2012;22(2):198-204. DOI: 10.5455/bcp.20120702032135

100. Dalkilic A, Cetin M. Editorial: past, present and future psychiatric trends in USA: lessons for all. Bulletin of Clinical Psychopharmacology 2012;22(3):205-9. DOI: 10.5455/bcp.20120912044306

101. Cetin M. Asenapine: A novel hope in the treatment of schizophrenia and manic and mixed episodes of bipolar I disorder. Bulletin of Clinical Psychopharmacology 2013;23(1):99-106. DOI: 10.5455/bcp.20130409040324

102. Pazvantoglu O, Algul A, Ateş MA, Sarisoy G, Ebrinc S, Basoglu C, Cetin M. Metacognitive functions in obsessive compulsive disorder in a Turkish clinical population: the relationship between symptom types and metacognition subdimensions .Bulletin of Clinical Psychopharmacology 2013; 23:65-71. DOI: 10.5455/bcp.20130127020802

103. Aydin N, Cetin M, Kurt E, Savas H, Acikel C, Kilic S, Basoglu C, Turkcapar H. A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Bulletin of Clinical Psychopharmacology 2013;23(4):390-402. DOI: 10.5455/bcp.20131230121254

104. Cetin M, Aricioglu F. Unmet needs in psychiatry and emerging novel pharmacological agents. Bulletin of Clinical Psychopharmacology 2013;23(3):199-204. DOI: 10.5455/bcp.20130927064824

105. Cetin M. Clozaphobia: Fear of Prescribers of Clozapine for Treatment of Schizophrenia. Bulletin of Clinical Psychopharmacology 2014;24(4):295-301. DOI: 10.5455/bcp.20141223052008

106. Cetin M, Aricioglu F. Sights For Sore Eyes and Disappointments in Psychopharmacology. Bulletin of Clinical Psychopharmacology 2014;24(2):111-4. DOI: 10.5455/bcp.20140626063115

107. Cetin M. Polypharmacy is a need in psychiatric practice. Bulletin of Clinical Psychopharmacology 2014;24:S49.

108. Cetin M.A Serious Risk: Excessive and inappropriate antipsychotic prescribing. Bulletin of Clinical Psychopharmacology 2014;24(1):1-4. DOI: 10.5455/bcp.20140314014626

109. Cetin M, Kilic S. Number needed to treat: an important measure for the accurate assessment of clinical significance. Bulletin of Clinical Psychopharmacology 2015;25(1):1-3. DOI: 10.5455/bcp.20140314014626

110. Cetin M. Treatment of schizophrenia: past, present and future. Bulletin of Clinical Psychopharmacology 2015;25(2):95-9. DOI: 10.5455/bcp.20150630080048

111. Tutuncu R, Kilic S, Basoglu C, Ates MA, Algul A, Balibey H, Gunay H, Semiz UB, Oge C, Ebrinc S, Cetin M. The Reliability and Validity of the Turkish Version of Psychopathy Checklist-Revised (Turkish PCL–R). Bulletin of Clinical Psychopharmacology 2015;25(2):118-24. DOI: 10.5455/bcp.20150310105903

112. Hizli-Sayar G, Cetin M. Over-the-counter purchase and off-label use of modafinil. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(3):312-3. DOI: 10.5455/bcp.20150720010841

113. Pan E, Ates MA, Algul A, Basoglu C, Aytekin A, Ebrinc S, Cetin M, Kose S. [0117] Schizophrenia and other psychotic disorders -Fractional anisotropic changes of the corpus callosum associated with antipsychotic treatment in first-episode antipsychotic drug-naive patients with schizophrenia. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(Suppl 1):S1-S3.

114. Balibey H, Basoglu C, Ates A, Algul A, Tutuncu R, Ayata A, Yilan Y, Cetin M. [Abstract:0535] Research methods in psychiatry – Eyes tell the psychopathology: preliminary findings. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(Supplement 1):S51-S2.

115. Meral G, Muftuoglu T, Basoglu C, Ates MA, Tutuncu R, Algul A, Balibey H, Ulus S, Ebrinc S, Cetin M Muftuoglu T. [Abstract:0385] Personality disorders and accentuated personality – Detection of the relationship between clinical features consisting of psychopathy levels and methylene tetrahydrofolate reductase (MTHFR) mutation among subjects with antisocial personality disorder. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(Suppl 1):S154.

116. Ozmut O, Balibey H, Yilan Y, Algul A, Ebrinc S, Cetin M, Tutuncu R, Ates A, Basoglu C. [Abstract:0137] Women’s mental health – Repetitive transcranial magnetic stimulation for the treatment of depression during pregnancy and postpartum period. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(Suppl 1):S203.

117. Ates A, Oner I, Tutuncu R, Basoglu C, Cetin M, Balibey H, Algul A, Ebrinc S. Relationship Between Plasma Levels of Prolactin and the Severity of Negative Symptoms in Patients with Schizophrenia. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(1):27-37. DOI: 10.5455/bcp.20141212113905

118. Hizli Sayar G, Cetin M. A Futuristic Approach to Psychiatric Diagnosis. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2015;25(4):321-5. DOI: 10.5455/bcp.20151115023922

119. Mifflin K, Benson C, Kerr B, Aricioglu F, Cetin M, Dursun S. Baker G. Involvement of Neuroactive Steroids in Pain, Depression and Anxiety. Finn DP, Leonard BE (eds): Pain in Psychiatric Disorders. Mod Trends Pharmacopsychiatry. Basel, Karger, 2015, vol 30, pp 94-102. Tutuncu RK, Selim B, Cengiz A, Mehmet AA, Ayhan B, Hakan G, Huseyin S, Umit BO, Cem ES, Cetin M. Turkish Psychopathy Checklist—Revised. 2015. DOI: 10.1159/000435935

120. Cetin M, Hizli Sayar G. Risk Evaluation and Mitigation Strategy for Clozapine. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2016;26(1):1-6. DOI: 10.5455/bcp.20160117032225

121. Hizli-Sayar G, Cetin M. Psychobiotics: the potential therapeutic promise of microbes in psychiatry. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2016;26(2):93-102.DOI: 10.5455/bcp.20160531111208

122. Sahin C, Dursun S, Cetin M, Aricioglu F. The neuroinflammation perspective of depression: reuniting the outstanding mechanisms of the pathophysiology. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2016;26(2):196-206. DOI: 10.5455/bcp.20160520092044

123. Kose S, Cetin M. ß-adrenergic Receptor Blocker Use for Traumatic Memory Reconsolidation in Posttraumatic Stress Disorder. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2016;26(3):215-22. DOI: 10.5455/bcp.20160927054221

124. Cetin M, Kose S. Updated clozapine treatment guide against clozaphobic attitudes. Journal of Mood Disorders (JMOOD) 2016;6(4):242-55. DOI: 10.5455/jmood.20161230061411

125. Thomas R, Cetin M, Baker GB, Dursun SM. Comment on FDA’s breakthrough therapy designation of intranasal esketamine for the treatment of major depressive disorder with imminent risk of suicide. Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2016;26(4):329-31. DOI: 10.5455/bcp.20161027122045

126. Pan E, Ates MA, Algul A, Aytekin A, Basoglu C, Ebrinc S, Cetin M, Kose S. Fractional anisotropic changes of corpus callosum associated with antipsychotic treatment in first-episode antipsychotic drug- Naive patients with schizophrenia.Clinical Psychopharmacology Bulletin – Bulletin of Clinical Psychopharmacology 2016;26(4):332-41. DOI: 10.5455/bcp.20160319021659

127. Aricioglu F, Sahin-Ozkartal C, Unal G, Dursun S, Cetin M, Muller N. Neuroinflammation in schizophrenia: a critical review and the future Clinical Psychopharmacology Bulteni – Bulletin of Clinical Psychopharmacology 2016;26 (4):429-37. DOI: 10.5455/bcp.20161123044657

128. Yilmaz O, Ates MA, Semiz UB, Tutuncu R, Bez Y, Algul A, Balibey H, Basoglu C, Ebrinc S, Cetin M. Childhood traumas in patients with bipolar disorder: association with alexithymia and dissociative experiences. Anatolian Journal of Psychiatry 2016; 17(3):188-195. DOI: 10.5455/apd.188358

129. Kraus M, Cetin M, Aricioglu F. The microbiota and gut-brain axis. Journal of Mood Disorders (JMOOD) 2016;6(3):172-9. DOI: 10.5455/jmood.20161004082122

130. Akin E, Cetin M, Kose S. An update on borderline personality disorder: life in the fast lane. Journal of Mood Disorders (JMOOD) 2017;7(1):65-72. DOI: 10.5455/jmood.20170308073312

131. Kose S, Cetin M. The Research Domain Criteria framework: transitioning from dimensional systems to integrating neuroscience and psychopathology. Psychiatry and Clinical Psychopharmacology 2017;27(1):1-5.DOI: 10.1080/24750573.2017.1293255

132. Kose S, Cetin M. Ketamine and electroconvulsive therapy pairing in depression and mood disorders. Psychiatry and Clinical Psychopharmacology 2017;27(2):103-105. DOI: 10.1080/24750573.2017.1332513

133. Kose S, Akin E, Cetin M. Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale. Psychiatry and Clinical Psychopharmacology 2017;27(2):210-211. DOI: 10.1080/24750573.2017.1332512

134. Kose S, Cetin M. Ketamine and rapastinel: NMDA receptor modulators in the rapid treatment of obsessive-compulsive disorder. Psychiatry and Clinical Psychopharmacology 2017;27(3):213-214. DOI: 10.1080/24750573.2017.1357355

135. Kose S, Cetin M. Brexanolone: an allosteric modulator of GABA-A receptors in the rapid treatment of postpartum depression. Psychiatry and Clinical Psychopharmacology. 2017;27(4):326-328. DOI: 10.1080/24750573.2017.1380352

136. Samet Kose & Mesut Cetin (2018) Cannabis-Asociated Psychotic Symptoms and Neurocognitive Effects at High Risk Patients, Psychiatry and Clinical Psychophall Psychopar , Doi: 10.1080/24750573.2018. 1403671

137. Samet Kose & Mesut Cetin (2018) Triple reuptake inhibitors (TRIs): do they promise us a rose garden?, Psychiatry and Clinical Psychopharmacology, 28:2, 119-122,DOI: 10.1080/24750573.2018.1443386

138. Samet Kose, Mesut Cetin (2018): Psychiatric pharmacogenomics in the age of neuroscience: promises and challenges, DOI: 10.1080/24750573.2018.1518191

139. Mesut Cetin & Samet Kose ( 2018): Serious dermatological effects of vortioxetine: two cases, Psychiatry and Clinical Psychopharmacology, DOI: 10.1080/24750573.2018.1484013

140. Derya Ozsavci, Özlem Bingol Ozakpinar, Mesut Cetin & Feyza Aricioglu(2019): Level of clinical evidence of herbal therapists in psychiatric disorders, Psychiatry and Clinical Psychopharmacology, DOI: 10.1080/24750573.2019.1625587

4.1.3. Book Editorships and Book Chapters
1.Mesut Çetin. Allergic Diseases and Bronchial Asthma from Psychomatic Perspective. Allergic Diseases and Bronchial Asthma/1. Skin. Bilmedya Group, Istanbul, 2004 Volume I. page:291-323
2. Mesut Çetin, Chapter 1. Brief History of Psychiatry, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page: 1-65.

3. Mesut Çetin, M.Emin Ceylan, Chapter 2. General Information, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, pages: 66-99.

4. Tarhan,N., Çetin,M.: Biological Indicators in Depression, Depression Monographs Series,. (Editor) Köroğlu E. Medikomat.Hekimler Yayın Birliği, Ankara, 1993 Vol.4, page: 175-200.

5. Çetin M. Tarhan N.: Psychoendocrinology of Depression, Depression Monographs Series.,. (Editor) Köroğlu E. Medikomat.Hekimler Yayın Birliği, Ankara, 1993 Vol.6, page: 253-281.

6. Innovations in Clinical Psychopharmacology-I “National Symposium” Book, Editors: Tarhan,N, Ceylan,ME, Çetin M, Istanbul, 1991.

7. Çetin,M., Evren C: Atypical Neuroleptics. Innovations in Clinical Psychopharmacology-IV “Symposium with International Participation” Book, Editors: Çetin M, Ağargün MY, Ebrinç S. Nobel Medicine Bookstores, Istanbul, 1998, pp: 92-135.

8. Çetin M. Comorbid diseases, differential diagnosis and management in antisocial personality disorder. (Editor: Erden C.) Antisocial Personality Disorder, Çorlu, 2002, p:17-29.

9. Çetin M. The Role of Psychological Factors in Allergy Etiology. (Editor: Aydilek R.): Allergic Diseases and Bronchial Asthma, Istanbul, 1998, Volume 1, pages: 277-300.

10. Mesut Çetin, Chapter 1. Brief history of psychiatry, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA . Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page:1-83

11. Mesut Çetin, M.Emin Ceylan Chapter 2. General Information, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page:83-125

12. Mesut Çetin, M.Emin Ceylan Chapter 3. Basic Psychopharmacology in Schizophrenia, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page:125-147

13. Mesut Çetin Chapter 32. Drug administration in terms of patient rights and ethics in psychiatry, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page: 839-849

14. Mesut Çetin, Chapter 33. General principles of psychopharmacotherapy, patient rights and ethics. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA.Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, pages: 849-861.

15. Mesut Çetin, Chapter 34. Fundamentals of action and side effects of antipsychotics. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page: 861-881

16. Mesut Çetin, M.Emin Ceylan, Chapter 35. Typical antipsychotics and clinical principles of antipsychotic treatment. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page: 991-937

17. Mesut Çetin, Chapter 36. New antipsychotics- I. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, pages: 937-997.

18. Mesut Çetin, Chapter 37. New antipsychotics- II. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, pages: 997-1019.

19. Mesut Çetin, Chapter 38. New antipsychotics and their side effects in clinical practice. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, pages: 1019-1067.

20. Mesut Çetin, Chapter 39. Various topics related to new antipsychotics. Biological Psychiatry, SCHIZOPHRENIA in Research and Clinical Practice.Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page: 1067-1117

21. Mesut Çetin, Chapter 53. Drug use in special situations. Biological Psychiatry, SCHIZOPHRENIA in Research and Clinical Practice. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, page: 1383-1403

22. Mesut Çetin, M.Emin Ceylan, Chapter 55. Tests used in schizophrenia. Biological Psychiatry, SCHIZOPHRENIA in Research and Clinical Practice. Editors M.Emin Ceylan, Mesut Çetin, 3rd edition; Küre Publishing Group, Istanbul, 2005, pages: 1178-1271.

23. M. Emin Ceylan, Mesut Çetin, Chapter 56. Tests used in schizophrenia. Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors 3rd edition; Küre Publishing Group, Istanbul, 2005, 1423-1496

24. M. Emin Ceylan, Mesut Çetin, Biological Psychiatry in Research and Clinical Practice, SCHIZOPHRENIA. Editors 3rd edition; Küre İletişim Grubu, İstanbul, 2005

25. Mesut Çetin, Ethics in Psychiatry, Clinical Psychiatry, Kaplan Sadock’s CLINICAL PSYCHIATRY HANDBOOK H. Aydın, A.Bozkurt (translation editors), Güneş Kitabevi, Ankara, 2005, p.615-619

26. Mesut Çetin, Servet Ebrinç, (editors) 1st National Psychopharmacology Congress 14-17 December 2005, Istanbul, Abstract Book of Papers, Istanbul, 2005

27. Mesut Çetin, Servet Ebrinç, (editors) 2nd National Psychopharmacology Congress, Abstract Book of Papers, Istanbul 2007

28. Mesut Çetin, Psikiyatrist ve Nörologlar için Klozapin El Kitabı, Bilmedya Grup,İstanbul,2023

4.1.4 Translated Books:
1. Mesut Çetin, (translation editor) Cognitive Behavioral Treatment of Obesity , Küre Publishing, Istanbul 2007
2.Feyza Arıcıoğlu, Mesut Çetin (translation editors) Stahl’ın Temel Psikofarmakolojisi Psikiyatri Reçete Yazım Kılavuzu, İstanbul Tıp Yayınevi, Istanbul,2023. https://www.amazon.com.tr/Stahl%C4%B1n-Psikofarmakolojisi-Psikiyatri-Re%C3%A7ete-K%C4%B1lavuzu/dp/6258103227
5. Awards:
• Ebrinç S., Başoğlu C., Yılmaz V., Çetin M. , Narin Y., “SPECT application in patients with major depression: Investigation of the effects of late partial sleep deprivation and antidepressive drug treatment on regional cerebral blood perfusion”. 3rd National Biological Psychiatry Congress, 18-21 June, Dedeman Hotel, Cappadocia, Nevşehir, 2001, Congress Poster Award.

• Çetin M. , Başoğlu C., Öner Ö., Ebrinç S., Semiz Ü.B., Kandilcioğlu H., “The effects of right thalamic and temporal cortex metabolic differences detected by 1H MRSI in patients with chronic schizophrenia in patients with first-episode psychotic disorder who did not use psychotropic drugs.” and comparison with healthy controls” 40th National Psychiatry Congress, 28 September-3 October 2004, Kuşadası, Turkish Psychiatric Association Poster Award.

• Başoğlu C., Çetin M. , Öner Ö., Ebrinç S., Semiz ÜB., Kandilcioğlu H, Şilet E, Kızılkaya E., “Comparison of right thalamus and temporal cortex metabolite levels in drug-naïve and chronic psychotic patients” Turkish Journal of Psychiatry Research Award, 2006.

• Pan E, Algül A, Başoğlu C, Ebrinç S, Çetin M., Aytekin A, Köse S. “Decreased fractional anisotropy in the corpus callosum in first-episode schizophrenia patients who did not receive antipsychotic drug treatment.” Oral Presentation First Prize, 46th National Psychiatry Congress, Izmir, 5-9 October, 2010.

• Algül A, Şen H, Ateş MA, Yen T, Durmaz O, Özkan S, Başoğlu C, Semiz ÜB, Ebrinç S, Dağlı G, Çetin M. “The effect of propofol and propofol remifentanil combination in electroconvulsive therapy on seizure duration and hemodynamics” Poster presentation Second Prize, 4th National Psychopharmacology Congress, Antalya, 23-27 November 2011.